Growth Hormone and Cardiovascular Risk Factors
نویسندگان
چکیده
منابع مشابه
Clinical Aspects Hormone Replacement Therapy’s Effect on Cardiovascular Risk Factors
Background: hormone replacement therapy (HRT) is still a controversial therapy, its effects over cardiovascular system being contradictory. Methods and material: we evaluated the HRT’s effects on cardiovascular risk factors on a 238 women (38 with and 200 without HRT) sample, between April 2007 and April 2008. For every woman, we investigated the cardiovascular risk factors’ presence. Results: ...
متن کاملPaternal Metabolic and Cardiovascular Risk Factors for Fetal Growth Restriction
OBJECTIVE Fathers of low-birth weight offspring are more likely to have type 2 diabetes and cardiovascular disease in later life. We investigated whether paternal insulin resistance and cardiovascular risk factors were evident at the time that fetal growth-restricted offspring were born. RESEARCH DESIGN AND METHODS We carried out a case-control study of men who fathered pregnancies affected b...
متن کاملMenopausal hormone therapy and cardiovascular disease risk: utility of biomarkers and clinical factors for risk stratification.
BACKGROUND Menopausal hormone therapy (HT) continues to have a clinical role in symptom management, but identifying women for whom benefits will outweigh the risks remains a challenge. Although hormone therapy (HT) is the most effective strategy for ameliorating vasomotor and other symptoms, randomized clinical trials show an unfavorable balance of benefits and risks for many women. However, cl...
متن کاملGrowth Hormone (GH) and Cardiovascular System
This review describes the positive effects of growth hormone (GH) on the cardiovascular system. We analyze why the vascular endothelium is a real internal secretion gland, whose inflammation is the first step for developing atherosclerosis, as well as the mechanisms by which GH acts on vessels improving oxidative stress imbalance and endothelial dysfunction. We also report how GH acts on corona...
متن کاملThe Decreased Growth Hormone Response to Growth Hormone Releasing Hormone in Obesity Is Associated to Cardiometabolic Risk Factors
The aim of the present study was to evaluate the relationship between GHRH-induced GH secretion in obese premenopausal women and cardiovascular risk markers or insulin resistance. Premenopausal obese women, aged 35-52 years, were studied. GH secretion, IGF-I, serum cardiovascular risk markers, insulin, leptin, mid-waist and hip circumference, total body fat, and truncal fat were measured. Subje...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Clinical Endocrinology & Metabolism
سال: 2005
ISSN: 0021-972X,1945-7197
DOI: 10.1210/jc.2004-0545